Disruptive Behavior Disorder
16
2
3
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
19%
3 trials in Phase 3/4
0%
0 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (16)
Personalizing Psychosocial Intervention for Children With Disruptive Behaviour
Matching Assessment and Treatment for Children With Disruptive Behaviour and Their Parents
Addressing Depression and Positive Parenting Techniques (ADAPT)
Evaluating Stress Management Strategies Within the School Readiness Parenting Program
Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior
Navigating Resource-Constrained Systems and Communities to Promote the Behavioral Health of Black Youth
Mindful Parenting and Parent Training Program Study
Behavioral Sleep Intervention in Children With Disruptive Behaviors
Improving Social, Emotional, Behavioral, and Academic Functioning
Mindfulness-based Program for Children With Disruptive Behavior Disorder
Enhancing the Outcomes of a Behavioral Parent Training Intervention
Addressing Behaviour and Treatment Effectiveness Project (A.B.A.T.E. Project)
Strongest Families Finland Canada: Family-based Prevention and Treatment Program of Early Childhood Disruptive Behavior
A Study of the Safety of Risperidone in the Treatment of Children and Adolescents With Conduct and Other Disruptive Behavior Disorders
A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild, Moderate, or Borderline Mental Retardation
A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation